57.0k views
0 votes
a patient with type 2 diabetes is started on the medication glyburide. which of the following statements by the patient causes concern?

User Laurentius
by
6.7k points

1 Answer

7 votes

Answer:

Step-by-step explanation:

-If this drug is used during pregnancy, it should be discontinued at least 2 weeks before the expected delivery date.

.Renal Dose Adjustments

Use with caution; initial and maintenance doses should be conservative to avoid hypoglycemic reactions

Initial dose: 1.25 mg (standard) or 0.75 mg (micronized) orally once a day

Liver Dose Adjustments

Use with caution; initial and maintenance doses should be conservative to avoid hypoglycemic reactions

Initial dose: 1.25 mg (standard) or 0.75 mg (micronized) orally once a day

Dose Adjustments

Initial and maintenance doses should be conservative in patients at risk for serious hypoglycemic reactions

Initial dose: 1.25 mg (standard) or 0.75 mg (micronized) orally once a day

Micronized glyburide tablets (Glynase Prestab) are not bioequivalent to standard glyburide formulations (DiaBeta, Micronase); patients should retitrate dose when transferring from one formulation to the other

No exact dosage relationship exists between glyburide and other oral hypoglycemic agents; however, a maintenance dose of glyburide 5 mg/day provides approximately the same degree of blood glucose control as chlorpropamide 250 to 375 mg/day, tolazamide 250 to 375 mg/day, acetohexamide 500 to 750 mg/day, or tolbutamide 1000 to 1500 mg/day.

Patients should not exceed maximum starting doses when switching agents

Precautions

CONTRAINDICATIONS:

Hypersensitivity to the active substance or any product excipients

Type 1 diabetes mellitus

Diabetic ketoacidosis, with or without coma

Concomitant administration of bosentan

Hypoglycemia may occur, especially in the elderly, debilitated, or malnourished patient, in patients receiving combination therapy, and/or those with renal, hepatic or adrenal insufficiency; dose reduction of this drug may be necessary.

This drug should not be used in patients with type 1 diabetes or diabetic ketoacidosis.

Hemolytic anemia may occur in glucose 6-phosphate dehydrogenase (G6PD) deficient patients; consider a non-sulfonylurea alternative.

When a patient stabilized on any diabetic regimen is exposed to stress such as fever, trauma infection, or surgery, it may be necessary to stop this drug and administer insulin.

User Thecarpy
by
8.5k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.